Abbas, Alkadar S.

HRN: 22-86-24  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/11/2023
CEFTRIAXONE 1G (VIAL)
04/11/2023
04/17/2023
IV
200mg
Q24
Pcap Severe
Waiting Final Action 
04/11/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/11/2023
04/17/2023
IV
60mg
Q24
Pcap Severe
Waiting Final Action 
04/14/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/14/2023
04/20/2023
IV DRIP
200 Mg
Q6hrs
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: